Good post BD. Following on your points and the pr
Post# of 148169
https://www.cancernetwork.com/news/fda-approv...-pneumonia
https://pharmaphorum.com/news/jury-still-out-...l-results/
As BD said, I don't have a problem with that necessarily. Remdesivir and tocilizumab, even if not perfect drugs (efficacy and safety seem to be issues in both), SHOULD be moved forward by the FDA right now if they are helping CV patients, even incrementally.
I'll be the loudest to cry "conspiracy" when leronlimab proves itself and remains unheralded and unapproved.
Until then, it sucks (like the Iranian FDA) to be patient ...